| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.001 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |